FDA
approval
· 2017-02-23
FDA Approved: HALOPERIDOL — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
Summary
The FDA approved a supplemental application for haloperidol from PAI Holdings (PAI Pharma) under ANDA073037, marking an additional approval action for this prod…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for HALOPERIDOL (HALOPERIDOL)